Kiniksa Pharmaceuticals International, plc 4 Filing

From the Filing

EDGAR Filing Documents for 0001532218-26-000004 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 4 - Statement of changes in beneficial ownership of securities: SEC Accession No. 0001532218-26-000004 Filing Date 2026-04-08 Accepted 2026-04-08 16:43:07 Documents 1 Period of Report 2026-04-06 Document Format Files Seq Description Document Type Size 1 form4-04082026_080403.html 4 1 form4-04082026_080403.xml 4 14690 Complete submission text file 0001532218-26-000004.txt 16315 Mailing Address C/O KINIKSA PHARMACEUTICALS, LTD. CLARENDON HOUSE, 2 CHURCH STREET HAMILTON D0 HM11 Business Address Patel Sanj K ( Reporting ) CIK : 0001532218 (see all company filings) Type: 4 | Act: 34 | File No.: 001-38492 | Film No.: 26848660 Mailing Address 105 PICCADILLY, SECOND FLOOR LONDON United Kingdom W1J 7NJ Business Address 105 PICCADILLY, SECOND FLOOR LONDON United Kingdom W1J 7NJ 7814319100 Kiniksa Pharmaceuticals International, plc ( Issuer ) CIK : 0001730430 (see all company filings) EIN. : 981795578 | Fiscal Year End: 1231 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)